Spotify Co-Founder’s Neko Health Lands in New York as Preventative Body Scans Spark Global Demand

Neko Health, the high-profile body-scanning startup co-founded by Spotify billionaire Daniel Ek and Hjalmar Nilsonne, has officially arrived in New York City, quickly establishing itself as one of the most talked-about wellness and preventative care innovations in the world today. Originating in Sweden, the company has leveraged advanced technology to screen patients for potential health issues related to the blood, skin, and metabolism, capturing the attention of consumers, venture capitalists, and the broader medical community alike.

According to the company, the global waitlist for a Neko Health scan has already surged past 300,000 people, reflecting an immense consumer appetite for proactive health monitoring. This rapid consumer interest accompanies a staggering financial backing, with the startup having raised nearly $1 billion in total funding as it looks to scale its operations internationally and establish a firm foothold in the United States.

TechCrunch recently sat down with Farooq Abbasi, a partner at Preface Ventures and an early investor in Neko Health, to discuss the startup’s trajectory, the state of preventative medicine, and the broader implications of introducing such technology to the American market. Abbasi hopes that Neko Health can serve as a cornerstone for the future of preventative medicine, particularly within a country like the United States, where the healthcare system is notoriously plagued by administrative complexities, high costs, and systemic inefficiencies.

Abbasi contends that preventative care utilization remains remarkably low across the U.S. primarily because everyday citizens harbor significant anxieties regarding out-of-pocket medical costs. Currently, Neko Health charges $500 for its comprehensive one-hour scanning session. While this service is not covered by traditional health insurance providers, the company notes that the fee should qualify as an eligible medical expense for individuals utilizing Health Savings Accounts, or HSAs.

"I think preventative care and healthcare should be cheap and accessible," Abbasi noted during the discussion, highlighting the ideological gap that current private and public healthcare models often fail to bridge for the average consumer.

The overarching hope among investors and company leadership is that Neko Health can directly tackle some of these deep-seated systemic issues by catching potential health markers early, thereby reducing long-term medical burdens. To achieve this, the startup is actively eyeing a broader expansion strategy across various major metropolitan areas in the United States.

For Abbasi, his endorsement of the product goes far beyond a standard venture capital investment. He has already undergone the Neko Health scan twice and admits, perhaps unsurprisingly, that he remains an enthusiastic proponent of the experience. "I think there should be Neko clinics everywhere," he stated.

Reflecting on the evolution of the startup’s technology, Abbasi pointed out how much the core product has developed and matured since he first tried it out as an early adopter. The iterative improvements in diagnostic capability highlight the rapid pace at which consumer health tech is advancing.

"In my generation one scan, it was a blood test with fifteen biomarkers," Abbasi recalled. "It was fifty-five this time."

This expansion in biomarker tracking illustrates the company’s commitment to deepening its analytical capabilities, offering patients a much wider lens through which to view their baseline physiological data during a single, streamlined appointment.

Beyond extensive blood work and metabolic evaluations, Neko Health also integrates advanced computer vision technology for its comprehensive skin and physical scans. For Abbasi, this application serves as yet another compelling example of how artificial intelligence is actively improving the broader medical and diagnostic sector. He strongly argues that Neko Health should not be dismissed as just another fleeting wellness fad or luxury trend, but rather viewed as a substantive tool that equips everyday people with actionable insights designed to genuinely improve their daily lives and long-term health outcomes.

Despite the immense hype and substantial financial backing, Neko Health still faces a long and challenging road ahead in the United States. The startup must navigate complex scaling hurdles, operational logistics, and rigorous regulatory approval processes that govern medical and health-related technologies in the American market.

Even so, Abbasi remains fundamentally optimistic about the path forward. He hopes that increased venture capital dollars will continue to flow into the right kinds of mission-driven companies, expressing a firm belief that no sector of the modern economy is too broken to be fixed by smart innovation and dedicated capital investment.